These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10567823)

  • 1. Iron deposits in the subthalamic nuclei in Hallervorden-Spatz disease.
    Müller T; Amoiridis G; Kuhn W; Przuntek H
    Eur Neurol; 1999; 42(4):240-1. PubMed ID: 10567823
    [No Abstract]   [Full Text] [Related]  

  • 2. Alpha-synuclein accumulation in a case of neurodegeneration with brain iron accumulation type 1 (NBIA-1, formerly Hallervorden-Spatz syndrome) with widespread cortical and brainstem-type Lewy bodies.
    Neumann M; Adler S; Schlüter O; Kremmer E; Benecke R; Kretzschmar HA
    Acta Neuropathol; 2000 Nov; 100(5):568-74. PubMed ID: 11045680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel histopathologic findings in molecularly-confirmed pantothenate kinase-associated neurodegeneration.
    Kruer MC; Hiken M; Gregory A; Malandrini A; Clark D; Hogarth P; Grafe M; Hayflick SJ; Woltjer RL
    Brain; 2011 Apr; 134(Pt 4):947-58. PubMed ID: 21459825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurodegeneration with brain iron accumulation: clinical, radiographic and genetic heterogeneity and corresponding therapeutic options.
    Clement F; Devos D; Moreau C; Coubes P; Destee A; Defebvre L
    Acta Neurol Belg; 2007 Mar; 107(1):26-31. PubMed ID: 17569231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging and Hallervorden-Spatz syndrome.
    Trimble M
    CNS Spectr; 2003 Jun; 8(6):420. PubMed ID: 12868452
    [No Abstract]   [Full Text] [Related]  

  • 6. Coexistence of TDP-43 and tau pathology in neurodegeneration with brain iron accumulation type 1 (NBIA-1, formerly Hallervorden-Spatz syndrome).
    Haraguchi T; Terada S; Ishizu H; Yokota O; Yoshida H; Takeda N; Kishimoto Y; Katayama N; Takata H; Akagi M; Kuroda S; Ihara Y; Uchitomi Y
    Neuropathology; 2011 Oct; 31(5):531-9. PubMed ID: 21276079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The eye-of-the-tiger sign is not a reliable disease marker for Hallervorden-Spatz syndrome.
    Baumeister FA; Auer DP; Hörtnagel K; Freisinger P; Meitinger T
    Neuropediatrics; 2005 Jun; 36(3):221-2. PubMed ID: 15944911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cranial MRI changes may precede symptoms in Hallervorden-Spatz syndrome.
    Hayflick SJ; Penzien JM; Michl W; Sharif UM; Rosman NP; Wheeler PG
    Pediatr Neurol; 2001 Aug; 25(2):166-9. PubMed ID: 11551748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hallervorden-Spatz syndrome.
    Vakili S; Drew AL; Von Schuching S; Becker D; Zeman W
    Arch Neurol; 1977 Dec; 34(12):729-38. PubMed ID: 201232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Striatal and pontocerebellar hypoperfusion in Hallervorden-Spatz syndrome.
    Castelnau P; Zilbovicius M; Ribeiro MJ; Hertz-Pannier L; Ogier H; Evrard P
    Pediatr Neurol; 2001 Aug; 25(2):170-4. PubMed ID: 11551749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hallervorden-Spatz syndrome.
    Dooling EC; Schoene WC; Richardson EP
    Arch Neurol; 1974 Jan; 30(1):70-83. PubMed ID: 4808495
    [No Abstract]   [Full Text] [Related]  

  • 12. [Magnetic resonance diagnosis of Hallervorden-Spatz disease].
    Bonetti M; Prandini F; Gasparotti R; Pavia M; Crispino M; Pittiani F
    Radiol Med; 1994 Dec; 88(6):869-70. PubMed ID: 7878250
    [No Abstract]   [Full Text] [Related]  

  • 13. [A case of Hallervorden-Spatz disease with magnetic resonance imaging data].
    Ruiz-Sandoval JL; García-Ramos G; Vega-Boada F; Estañol-Vidal B
    Rev Invest Clin; 1998; 50(3):249-53. PubMed ID: 9763892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late-onset Hallervorden-Spatz disease presenting as familial parkinsonism.
    Jankovic J; Kirkpatrick JB; Blomquist KA; Langlais PJ; Bird ED
    Neurology; 1985 Feb; 35(2):227-34. PubMed ID: 3969211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Images in neurology. Neurodegeneration with pantothenate kinase syndrome: retinal and magnetic resonance imaging findings.
    Gadodia A; Kumar A; Sankhyan N; Sharma S; Vasisht N
    Arch Neurol; 2009 Jun; 66(6):798-9. PubMed ID: 19506146
    [No Abstract]   [Full Text] [Related]  

  • 16. Hallervorden-Spatz syndrome resembling a typical Tourette syndrome.
    Scarano V; Pellecchia MT; Filla A; Barone P
    Mov Disord; 2002 May; 17(3):618-20. PubMed ID: 12112223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generalized freezing in Hallervorden-Spatz syndrome: case report.
    Guimarães J; Santos JV
    Eur J Neurol; 1999 Jul; 6(4):509-13. PubMed ID: 10362909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging in pathologically proven Hallervorden-Spatz disease.
    Schaffert DA; Johnsen SD; Johnson PC; Drayer BP
    Neurology; 1989 Mar; 39(3):440-2. PubMed ID: 2927660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hallervorden-Spatz syndrome: clinical and magnetic resonance imaging correlations.
    Sethi KD; Adams RJ; Loring DW; el Gammal T
    Ann Neurol; 1988 Nov; 24(5):692-4. PubMed ID: 3202617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generalised dystonia: clinical diagnosis is possible.
    Chacko B; Seshadri P; Sudarsanam TD
    Hong Kong Med J; 2009 Jun; 15(3):224-6. PubMed ID: 19494381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.